Integrated genomic analyses of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Integrated genomic analyses of hepatocellular carcinoma

Published:2022-12-06 Issue:1 Volume:17 Page:97-111
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Chang Ya-Sian,Tu Siang-Jyun,Chen Hong-Da,Hsu Ming-Hon,Chen Yu-Chia,Chao Dy-San,Chung Chin-Chun,Chou Yu-Pao,Chang Chieh-Min,Lee Ya-Ting,Yen Ju-Chen,Jeng Long-Bin,Chang Jan-Gowth^ORCID

Funder

China Medical University Hospital

Ministry of Science and Technology

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-022-10455-z.pdf

Reference53 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. https://doi.org/10.3322/caac.21660

2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. https://doi.org/10.3322/caac.21654

3. McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(Suppl 1):4–13. https://doi.org/10.1002/hep.31288

4. Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. https://doi.org/10.1038/s41572-020-00240-3

5. Yu MW, Lin CL, Liu CJ, Yang SH, Tseng YL, Wu CF. Influence of Metabolic Risk Factors on risk of hepatocellular carcinoma and liver-related death in men with chronic hepatitis B a large cohort study. Gastroenterology. 2017;153(4):1006-1017 e5. https://doi.org/10.1053/j.gastro.2017.07.001

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Boolean model explains phenotypic plasticity changes underlying hepatic cancer stem cells emergence;npj Systems Biology and Applications;2024-09-02

2. Aristolochic acids-hijacked p53 promotes liver cancer cell growth by inhibiting ferroptosis;Acta Pharmacologica Sinica;2024-08-01

3. Novel genetic alterations in liver cancer distinguish distinct clinical outcomes and combination immunotherapy responses;Frontiers in Pharmacology;2024-06-14

4. Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients;2024-04-30

5. The Adaptive Immune Response in Hepatitis B Virus-Associated Hepatocellular Carcinoma Is Characterized by Dysfunctional and Exhausted HBV-Specific T Cells;Viruses;2024-04-29